Status:
UNKNOWN
The Injection-Related InfectionS (IRIS) Program
Lead Sponsor:
McMaster University
Collaborating Sponsors:
HAMSMaRT
Keeping Six
Conditions:
Peer Support
Injection-related Infections
Eligibility:
All Genders
16-105 years
Phase:
NA
Brief Summary
People who inject drugs are at risk of injection-related infections, like abscesses or infective endocarditis. The Injection-Related InfectionS (IRIS) program hopes to improve treatment for participan...
Eligibility Criteria
Inclusion
- Age 16 or older
- Able to provide informed consent
- Presenting with a confirmed or suspected injection-related infection (including skin and soft tissue infections, osteomyelitis, infective endocarditis, Hepatitis C, HIV, etc)
- History of injection drug use within 3 months of recruitment
- Lives in Hamilton, Ontario
Exclusion
- \-
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06169553
Start Date
January 1 2024
End Date
December 1 2025
Last Update
December 13 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
HAMSMaRT Clinic
Hamilton, Ontario, Canada, L8M 1J3
2
David Braley Health Science Centre
Hamilton, Ontario, Canada, L8P 1H6